Exchange Traded Concepts, LLC Denali Therapeutics Inc. Transaction History

Exchange Traded Concepts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 17, 2023	BUY	$26.28 - $33.92 $10,722 - $13,839	408 Added 18.75%	2,584 $72,000
Q3 2022 Oct 07, 2022	BUY	$25.97 - $38.53 $7,842 - $11,636	302 Added 16.12%	2,176 $67,000
Q2 2022 Jul 20, 2022	BUY	$20.88 - $35.19 $28,856 - $48,632	1,382 Added 280.89%	1,874 $55,000
Q1 2022 Apr 26, 2022	BUY	$29.0 - $47.27 $14,268 - $23,256	492 New	492 $16,000
Q2 2021 Jul 30, 2021	SELL	$50.3 - $78.44 $6,287 - $9,805	-125 Closed	0 $0
Q1 2021 Apr 20, 2021	SELL	$53.8 - $81.53 $20,444 - $30,981	-380 Reduced 75.25%	125 $7,000
Q4 2020 Jan 19, 2021	BUY	$36.89 - $93.56 $18,629 - $47,247	505 New	505 $42,000

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.